EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol

M Kati Lear, Sarah M Smith, Brian Pilecki, Chris S Stauffer, Jason B Luoma

Frontiers in Psychiatry · 14.07.2023 · 14

DOI: 10.3389/fpsyt.2023.1083354 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Frontiers in Psychiatry, online erschienen am 14.07.2023. Verfasst von M Kati Lear und 4 weiteren Autor:innen. Beteiligte Einrichtung: Portland Psychotherapy Clinic, Research, and Training Center, Portland, OR, United States. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Social anxiety disorder (SAD) is a serious and prevalent psychiatric condition that heavily impacts social functioning and quality of life. Though efficacious treatments exist for SAD, remission rates remain elevated and a significant portion of those affected do not access effective treatment, suggesting the need for additional evidence-based treatment options. This paper presents a protocol for an open-label pilot study of MDMA-assisted therapy (MDMA-AT) for social anxiety disorder. The study aims to assess preliminary treatment outcomes, feasibility and safety, and psychological and physiological processes of change in the treatment of SAD with MDMA-AT. A secondary aim includes the development of a treatment manual for MDMA-AT for SAD.

Method

The outlined protocol is a randomized, open-label delayed treatment study. We will recruit 20 participants who meet criteria with moderate-to-severe social anxiety disorder (SAD) of the generalized subtype. Participants will be randomly assigned to an immediate treatment ( n = 10) or delayed treatment condition ( n = 10). Those in the immediate treatment condition will proceed immediately to active MDMA-AT consisting of three preparation sessions, two medicine sessions in which they receive oral doses of MDMA, and six integration sessions over approximately a 16-week period. The delayed treatment condition will receive the same intervention after a 16-week delay. Our primary outcome is SAD symptom reduction as measured by the Liebowitz Social Anxiety Scale administered by blinded raters at post-treatment and 6 month follow up. Secondary outcomes include changes in functional impairment, feasibility and safety measures, and novel therapeutic processes of change including shame and shame-related coping, belongingness, self-concealment, and self-compassion at post-treatment. Exploratory outcomes are also discussed.

Discussion

The results of this pilot trial advance the field’s understanding of the acceptability and potential effectiveness of MDMA-AT for social anxiety disorder and provide an overview of relevant therapeutic mechanisms unique to SAD. We hope findings from this protocol will inform the design of subsequent larger-scale randomized controlled trials (RCT) examining the efficacy of MDMA-AT for SAD. Clinical trial registration https://clinicaltrials.gov/ , NCT05138068.

Schlagwörter

Stichwörter der Autor:innen

MDMAclinical trial protocolpsychedelic assisted therapypsychedelic researchsocial anxiety disorder

Autor:innen und Institutionen

  • Portland Psychotherapy Clinic, Research, and Training Center, Portland, OR, United States.
  • Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.

Zitieren

APA

Lear, M. K., Smith, S. M., Pilecki, B., Stauffer, C. S., & Luoma, J. B. (2023). Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1083354

Vancouver

Lear MK, Smith SM, Pilecki B, Stauffer CS, Luoma JB. Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1083354

BibTeX
@article{Lear2023,
  author = {Lear, M Kati and Smith, Sarah M and Pilecki, Brian and Stauffer, Chris S and Luoma, Jason B},
  title = {Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol},
  journal = {Frontiers in Psychiatry},
  year = {2023},
  volume = {14},
  doi = {10.3389/fpsyt.2023.1083354}
}
Kostenlos starten →